Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2525]

PARP inhibitor rucaparib becomes new treatment option for some men with advanced prostate cancer

PARP inhibitor rucaparib becomes new treatment option for some men with advanced prostate cancer

Researchers discover the microbiome's role in attacking cancerous tumours

Researchers discover the microbiome's role in attacking cancerous tumours

Delaying prostate cancer radiation therapy offers room for flexibility in pandemic peak

Delaying prostate cancer radiation therapy offers room for flexibility in pandemic peak

Radiation to treat paediatric cancers may have lasting impact on heart and metabolic health

Radiation to treat paediatric cancers may have lasting impact on heart and metabolic health

Clarifying the role of cohesine in cancer and cardiac development

Clarifying the role of cohesine in cancer and cardiac development

NICE recommends avelumab with axitinib for first-line treatment of adult patients with advanced renal cell carcinoma (ARCC)

NICE recommends avelumab with axitinib for first-line treatment of adult patients with advanced renal cell...

Night-time exposure to blue light associated with increased risk of colorectal cancer

Night-time exposure to blue light associated with increased risk of colorectal cancer

Acute exercise has beneficial effects on the immune system during prostate cancer

Acute exercise has beneficial effects on the immune system during prostate cancer

New blood test can confirm prostate cancer – and what stage it is at

New blood test can confirm prostate cancer – and what stage it is at

Artificial intelligence identifies prostate cancer with near-perfect accuracy

Artificial intelligence identifies prostate cancer with near-perfect accuracy

More from ecancer